1. You are here:
  2. Research
  3. Research Articles
  4. 2013 Articles

2013 Articles

Pharmacokinetics of angiotensin II receptor blockers in the dog following a single oral administration.
Baek IH, Lee BY, Lee ES, Kwon KI.
Drug Res. (Stuttg.), 2013, 63, 357–361.

Identification of alpha-cobratoxin in equine plasma by LC-MS/MS for doping control.
Bailly-Chouriberry L, Cormant F, Garcia P, Kind A, Popot MA, Bonnaire Y.
Anal. Chem., 2013, 85, 5219–5225.

Metabolism of norethisterone in the greyhound.
Biddle ST, O'Donnell A, Houghton E, Creaser CS.
Rapid Commun. Mass Spectrom., 2013, 27, 2229–2238.

Pharmacokinetics and perioperative efficacy of intravenous ketorolac in dogs.
Cagnardi P, Zonca A, Gallo M, Villa R, Carli S, Beccaglia M, Fonda D, Ravasio G.
J. Vet. Pharmacol. Ther., 2013, 36, 603–608.

Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses.
Casbeer HC, Knych HK.
Vet. J., 2013, 196, 504–509.

Real time monitoring of propofol blood concentration in ponies anaesthetized with propofol and ketamine.
De Vries A, Taylor PM, Troughton G, Liu B, Fowden AL, Sear JW.
J. Vet. Pharmacol. Therap., 2013, 36, 258–266.

The analysis of pergolide residues in horse plasma by LC with fluorescence detection.
Doran G, Hughes K, Rendle D, Edwards S.
J. AOAC Int., 2013, 96, 1487–1493.

Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog.
Elisabeth JC, Marc S, Frederique W, Mathieu F, Herve LP, Pierre-Louis T.
BMC Vet. Res., 2013, 9, 250.

The chiral bioconversion and preclinical pharmacokinetic analysis of (R)-(+)-rabeprazole in beagle dogs by HPLC and HPLC-MS/MS.
Gao YH, Xu JX, Su ZX, Song L, Lou HX.
Biomed. Chromatogr., 2013, 27, 1380–1386.

Development of a supercritical fluid chromatography-tandem mass spectrometry method for the determination of lacidipine in beagle dog plasma and its application to a bioavailability study.
Geng Y, Zhao L, Zhao J, Guo B, Ma P, Li Y, Zhang T.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 945–946, 121–126.

Detection of fluticasone propionate in horse plasma and urine following inhaled administration.
Gray BP, Biddle S, Pearce CM, Hillyer L.
Drug Test. Anal., 2013, 5, 306–314.

Investigations into the feasibility of routine ultra high performance liquid chromatography-tandem mass spectrometry analysis of equine hair samples for detecting the misuse of anabolic steroids, anabolic steroid esters and related compounds.
Gray BP, Viljanto M, Bright J, Pearce C, Maynard S.
Anal. Chim. Acta., 2013, 787, 163–172.

Detection, quantification, and identification of dermorphin in equine plasma and urine by LC-MS/MS for doping control.
Guan F, Uboh CE, Soma LR, Robinson M, Maylin GA, Li X.
Anal. Bioanal. Chem., 2013, 405, 4707–4017.

In vitro diazepam metabolism in horses.
Hayami A, Darwish WS, Ikenaka Y, Nakayama SM, Ishizuka M.
Jpn. J. Vet. Res., 2013, 61 Suppl., 82–84.

High resolution accurate mass screening of prohibited substances in equine plasma using liquid chromatography – Orbitrap mass spectrometry.
Ho ENM, Kwok WH, Wong ASY, Wan TSM.
Drug Test. Anal., 2013, 5, 509–528.

Pharmacokinetics of midazolam after intravenous administration to horses.
Hubbell JAE, Kelly EM, Aarnes TK, Bednarski RM, Lerche P, Liu Z, Lakritz J.
Equine Vet. J., 2013, 45, 721–725.

Ultra high performance liquid chromatography/tandem mass spectrometry based identification of steroid esters in serum and plasma: An efficient strategy to detect natural steroids abuse in breeding and racing animals.
Kaabia Z, Dervilly-Pinel G, Hanganu F, Cesbron N, Bichon E, Popot MA, Bonnaire Y, Le Bizec B.
J. Chromatogr. A, 2013, 1284, 126–140.

Individual identification of racehorses from urine samples using a 26-plex single-nucleotide polymorphism assay.
Kakoi H, Kijima-Suda I, Gawahara H, Kinoshita K, Tozaki T, Hirota KI, Yoshizawa M.
J. Forensic Sci., 2013, 58, 21–28.

A generic screening methodology for horse doping control by LC-TOF-MS, GC-HRMS and GC-MS.
Kioussi MK, Lyris EM, Angelis YS, Tsivou M, Koupparis MA, Georgakopoulos CG.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 941, 69–80.

Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse.
Knych HK, Casbeer HC, McKemie DS, Arthur RM.
J. Vet. Pharmacol. Ther., 2013, 36, 21–30.

Pharmacokinetics and pharmacodynamics of tramadol in horses following oral administration.
Knych HK, Corado CR, McKemie DS, Scholtz E, Sams R.
J. Vet Pharmacol. Ther., 2013, 36, 389–398.

Pharmacokinetics and selected pharmacodynamic effects of tramadol following intravenous administration to the horse.
Knych HK, Corado CR, McKemie DS, Steffey EP.
Equine Vet. J., 2013, 45, 490–496.

Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.
Knych HK, Vidal MA, Casbeer HC, McKemie DS.
Equine Vet. J., 2013, 45, 715–720.

Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
Kwok WH, Ho EN, Lau MY, Leung GN, Wong AS, Wan TS.
Anal. Bioanal. Chem., 2013, 405, 2595–2606.

Metabolic studies of 1-testosterone in horses.
Kwok WH, Ho ENM, Leung GNW, Tang FPW, Wan TSM, Wong HNC, Yeung JHK.
Drug Test. Anal., 2013, 5, 81–88.

Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses.
Lees P, Toutain PL.
Vet. J., 2013, 196, 294–303.

The pharmacokinetics of maropitant citrate dosed orally to dogs at 2 mg/kg and 8 mg/kg once daily for 14 days consecutive days.
Lesman SP, Boucher JF, Grover GS, Cox SR, Bidgood TL.
J. Vet. Pharmacol. Ther., 2013, 36, 462–470.

Metabolic studies of formestane in horses.
Leung GNW, Kwok WH, Wan TSM, Lam KKH, Schiff PJ.
Drug Test. Anal., 2013, 5, 412–419.

Development and validation of a rapid and sensitive assay for the determination of anisodamine in 50 μL of beagle dog plasma by LC-MS/MS.
Li W, Wen J, He J, Cao D, Sun F, Li J, Fan G.
J. Sep. Sci., 2013, 36, 3184–3190.

Determination of antazoline hydrochloride in beagle dog plasma by HPLC-UV and its application to pharmacokinetics.
Li X, Chu Y, Ke Y, Wang L, Yu T, Hao L.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 929, 97–101.

Sensitive hydrophilic interaction liquid chromatography/tandem mass spectrometry method for rapid detection, quantification and confirmation of cathinone-derived designer drugs for doping control in equine plasma.
Li X, Uboh CE, Soma LR, Liu Y, Guan F, Aurand CR, Bell DS, You Y, Chen J, Maylin GA.
Rapid Commun. Mass Spectrom., 2013, 28, 217–229.

Studies on separation and pharmacokinetics of m-nisoldipine enantiomers in beagle dog plasma by LC/MS/MS.
Li M, Yuan L, Li X, Zhi X, Sheng N, Zhang L.
J. Pharm. Biomed. Anal., 2013, 85, 61–66.

A Bayesian approach for estimating detection times in horses: exploring the pharmacokinetics of a urinary acepromazine metabolite.
McGree JM, Noble G, Schneiders F, Dunstan AJ, McKinney AR, Boston R, Sillence M.
J. Vet. Pharmacol. Ther., 2013, 36, 31–42.

The metabolism of anabolic-androgenic steroids in the greyhound.
McKinney AR, Cawley AT, Young EB, Kerwick CM, Cunnington K, Stewart RT, Ambrus JI, Willis AC, McLeod MD.
Bioanalysis, 2013, 5, 769–781.

Pharmacokinetics of stanozolol in thoroughbred horses following intramuscular administration.
Moeller BC, Sams RA, Guingab-Cagmat JD, Szabo NJ, Colahan P, Stanley SD.
J. Vet. Pharmacol. Ther., 2013, 36, 201–204.

Diurnal rhythm and effects of feeding, exercise and recombinant equine growth hormone on serum insulin concentrations in the horse.
Noble GK, Sillence MN.
Equine Vet. J., 2013, 45, 745–750.

Plasma concentrations and therapeutic effects of budesonide in dogs with inflammatory bowel disease.
Pietra M, Fracassi F, Diana A, Gazzotti T, Bettini G, Peli A, Morini M, Pagliuca G, Roncada P.
Am. J. Vet. Res., 2013, 74, 78–83.

Detection and quantification of dermorphin and selected analogs in equine urine.
Richards SL, Cawley AT, Raftery MJ.
Bioanalysis, 2013, 5, 2995–3007.

The pharmacokinetics of midazolam after intravenous, intramuscular, and rectal administration in healthy dogs.
Schwartz M, Muñana KR, Nettifee-Osborne JA, Messenger KM, Papich MG.
J. Vet. Pharmacol. Ther., 2013, 36, 471–477.

Pharmacokinetics of ammonium sulfate gradient loaded liposome-encapsulated oxymorphone and hydromorphone in healthy dogs.
Smith LJ, Kukanich BK, Krugner-Higby LA, Schmidt BH, Heath TD.
Anal. Chem., 2013, 40, 537–545.

Pharmacokinetics of dexamethasone following intra-articular, intravenous, intramuscular, and oral administration in horses and its effects on endogenous hydrocortisone.
Soma LR, Uboh CE, Liu Y, Li X, Robinson MA, Boston RC, Colahan PT.
J. Vet. Pharmacol. Ther., 2013, 36, 181–191.

The levels of zearalenone and its metabolites in plasma, urine and faeces of horses fed with naturally, Fusarium toxin–contaminated oats.
Songsermsakul P, Böhm J, Aurich C, Zentek J, Razzazi-Fazeli E.
J. Anim. Physiol. Anim. Nutr., 2013, 97, 155–161.

Pharmacokinetics and adverse effects of oral meloxicam tablets in healthy adult horses.
Vander Werf1 KA, Davis EG, KuKanich B.
J. Vet Pharmacol. Ther., 2013, 36, 376–381.

Pharmacokinetics of 8-O-acetylharpagide and harpagide after oral administration of Ajuga decumbens extract in beagle dog.
Wen BY, Li JR.
Zhongguo Zhong Yao Za Zhi., 2013, 38, 2015–2018.

Detection and elimination profile of cathinone in equine after norephedrine (Propalin®) administration using a validated liquid chromatography–tandem mass spectrometry method.
Yi R, Zhao S, Lam G, Sandhu J, Loganathan D, Morrissey B.
Anal. Bioanal. Chem., 2013, 405, 9711–9722.

Simultaneous determination of harmine, harmaline and their metabolites harmol and harmalol in beagle dog plasma by UPLC-ESI-MS/MS and its application to a pharmacokinetic study.
Zhang L, Teng L, Gong C, Liu W, Cheng X, Gu S, Deng Z, Wang Z, Wang C.
J. Pharm. Biomed. Anal., 2013, 85, 162–168.